An announcement from Harmony Biosciences Holdings (HRMY) is now available.
Jack Bech Nielsen has resigned with immediate effect from the Board of Harmony Biosciences Holdings, Inc. due to health reasons, with no disagreements cited regarding company operations. Meanwhile, Harmony Biosciences Holdings, Inc. has renamed its subsidiary from “Zynerba Pharmaceuticals, Inc.” to “Harmony Biosciences Management, Inc.” as of July 1, 2024.
For detailed information about HRMY stock, go to TipRanks’ Stock Analysis page.
